Adma Biologics: Fourth Quarter Financial Overview

ADMA Biologics Announces Fourth-Quarter Financial Results

ADMA Biologics Inc., headquartered in Ramsey, New Jersey, has released its financial results for the fourth quarter, reporting earnings of $49.4 million.

The company stated that its net income for the quarter was $0.20 per share.

During this period, the infectious disease treatment developer generated $139.2 million in revenue.

Looking at the full year, ADMA Biologics achieved a profit of $146.9 million, translating to $0.60 per share, with annual revenue reaching $510.2 million.

For the upcoming year, the company projects total revenue to reach $635 million.

Since the start of the year, ADMA Biologics' stock price has declined by 14%. However, by the close of trading on Wednesday, shares were valued at $15.68, reflecting an increase of nearly 2% over the past year.